Setterwalls advised Promore Pharma AB on the deal.Promore Pharma AB completed its rights issue of approximately SEK 48.6 million. Promore Pharma is a biopharmaceutical company specialized…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Federica Tiefenthaler
…
This content is for Standard 1 Year members only. LoginJoin Now